Disc Medicine, Inc. (NASDAQ:IRON) Given Average Recommendation of “Buy” by Brokerages
Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has been assigned an average rating of “Buy” from the ten brokerages that are currently covering the stock, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target […]
Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) has been assigned an average rating of “Buy” from the ten brokerages that are currently covering the stock, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target […]
